Cargando…
Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study
Oral bisphosphonates are first-line drugs in the treatment of osteoporosis under most guidelines, and have been shown to decrease risk of first fracture only in asymptomatic vertebral fractures and in clinical trial populations that are generally very different from the general population. OBJECTIVE...
Autores principales: | Real, Jordi, Galindo, Gisela, Galván, Leonardo, Lafarga, María Antonia, Rodrigo, María Dolors, Ortega, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393307/ https://www.ncbi.nlm.nih.gov/pubmed/25861000 http://dx.doi.org/10.1371/journal.pone.0118178 |
Ejemplares similares
-
Role of Bisphosphonates in Postmenopausal Women with Osteoporosis to Prevent Future Fractures: A Literature Review
por: Imam, Bashir, et al.
Publicado: (2019) -
Oral bisphosphonate use and lung cancer incidence among postmenopausal women
por: Tao, M H, et al.
Publicado: (2018) -
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016) -
Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy
por: Kostoff, Matthew D, et al.
Publicado: (2014) -
Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
por: Kim, Hong Jin, et al.
Publicado: (2023)